Parsia A Vagefi

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Downstaging of hepatocellular carcinoma prior to liver transplant: is there a role for adjuvant sorafenib in locoregional therapy?
    Parsia A Vagefi
    Division of Transplantation, University of California, San Francisco, CA 94143, USA
    J Gastrointest Cancer 41:217-20. 2010
  2. pmc Emergent orthotopic liver transplantation for hemorrhage from a giant cavernous hepatic hemangioma: case report and review
    Parsia A Vagefi
    Division of Transplant Surgery, University of California, San Francisco, San Francisco, CA 94143, USA
    J Gastrointest Surg 15:209-14. 2011
  3. doi Outcomes with split liver transplantation in 106 recipients: the University of California, San Francisco, experience from 1993 to 2010
    Parsia A Vagefi
    Division of Transplant Surgery, Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA
    Arch Surg 146:1052-9. 2011
  4. doi Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation
    Parsia A Vagefi
    Division of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA
    Liver Transpl 18:160-5. 2012
  5. doi Native renal function after combined liver-kidney transplant for type 1 hepatorenal syndrome: initial report on the use of postoperative Technetium-99 m-mercaptoacetyltriglycine scans
    Parsia A Vagefi
    Department of Surgery, Massachusetts General Hospital Harvard Medical School, Boston, MA, USA
    Transpl Int 26:471-6. 2013

Detail Information

Publications5

  1. pmc Downstaging of hepatocellular carcinoma prior to liver transplant: is there a role for adjuvant sorafenib in locoregional therapy?
    Parsia A Vagefi
    Division of Transplantation, University of California, San Francisco, CA 94143, USA
    J Gastrointest Cancer 41:217-20. 2010
    ..We present a patient with HCC who underwent treatment with sorafenib, which resulted in a remarkable reduction in tumor burden to allow for liver transplant listing...
  2. pmc Emergent orthotopic liver transplantation for hemorrhage from a giant cavernous hepatic hemangioma: case report and review
    Parsia A Vagefi
    Division of Transplant Surgery, University of California, San Francisco, San Francisco, CA 94143, USA
    J Gastrointest Surg 15:209-14. 2011
    ..The optimal surgical management of symptomatic hepatic hemangiomas remains controversial, with resection, enucleation, and both deceased donor and living donor liver transplantation having been reported...
  3. doi Outcomes with split liver transplantation in 106 recipients: the University of California, San Francisco, experience from 1993 to 2010
    Parsia A Vagefi
    Division of Transplant Surgery, Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA
    Arch Surg 146:1052-9. 2011
    ..Split liver transplantation (SLT) allows for expansion of the deceased donor pool...
  4. doi Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation
    Parsia A Vagefi
    Division of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA
    Liver Transpl 18:160-5. 2012
    ..These differences can be hypothesized to be driven in part by the relative availability of LDLT versus DDLT at both the patient level and the DSA level...
  5. doi Native renal function after combined liver-kidney transplant for type 1 hepatorenal syndrome: initial report on the use of postoperative Technetium-99 m-mercaptoacetyltriglycine scans
    Parsia A Vagefi
    Department of Surgery, Massachusetts General Hospital Harvard Medical School, Boston, MA, USA
    Transpl Int 26:471-6. 2013
    ....